To gain insights on the application, use and effectiveness of Frisolac Gold Intensive HA and Frisolac Gold PEP AC with reference to improvement of CMPA symptoms and to determine the methodology used by Mexican Health Care Professionals (HCPs) in the clinical practice (i.e. diagnosis and dietary management) of CMPA in Mexican children (≤24 months) diagnosed with or suspected of CMPA.
Study Type
OBSERVATIONAL
Enrollment
79
Regular medical care
Clinica San Antonio
Mexico City, Mexico
Clínica de Alergia Pediátrica
Pachuca, Mexico
Consultorio de Pediatria
Pachuca, Mexico
Hospital del Niño DIF
Pachuca, Mexico
Growth
* the proportion of subjects with weight gain compared to the previous visit (%) * the proportion of subjects with height gain compared to the previous visit (%) * the proportion of subjects with both weight and height gain compared to the previous visit (%)
Time frame: Can be 2 weeks up to 2 months
Dermatological symptoms (SCORAD score)
The proportion of subjects with an 1-point improvement in their SCORAD intensity category in between 2 visits (%)
Time frame: Can be 2 weeks up to 2 months
Type of symptoms
Type of symptoms (e.g. crying, regurgitation, stool consistency, respiratory, enteropathies and colitis) (based on clinical diagnosis)
Time frame: Can be 2 weeks up to 2 months
Number of symptoms
Number of symptoms (e.g. crying, regurgitation, stool consistency, respiratory, enteropathies and colitis) (based on clinical diagnosis)
Time frame: Can be 2 weeks up to 2 months
Severity of symptoms
Severity of symptoms on first and second visit (based on clinical diagnosis)
Time frame: Can be 2 weeks up to 2 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.